Senior insider sale
Chief Operating Officer at PALVELLA THERAPEUTICS, INC. — senior position signals high conviction
$2.42M
17.21K shares
What this filing means
GOIN KATHLEEN plans to sell 17.21K shares of PALVELLA THERAPEUTICS, INC. valued at approximately $2.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001967940-26-000051
Officer· Chief Operating Officer
Since Feb 2026
17.21K
Shares to sell
$2.42M
Approx. market value
4.30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/16/2026
4.30KTotal acquired4.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2026 | Stock Option Exercise Cash | 4.30K | — |
| Total | 4.30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.30K
Market value
$654.8K
8/19/2026
—Completed
Units to sell
4.30K
Market value
$642.2K
7/15/2026
—Completed
Units to sell
4.30K
Market value
$476.4K
6/17/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.30K
Market value
$650.5K
9/16/2026
Total
Units
17.21K
Value
$2.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2026 | 4.30K | $654.8K | — | Completed |
7/15/2026 | 4.30K | $642.2K | — | Completed |
6/17/2026 | 4.30K | $476.4K | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 4.30K | $650.5K | Nasdaq | Planned |
| Total | 17.21K | $2.42M | ||